148 related articles for article (PubMed ID: 30553168)
1. Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis.
Leurs CE; Lopes Pinheiro MA; Wierts L; den Hoedt S; Mulder MT; Eijlers AJC; Schoonheim MM; Balk LJ; Uitdehaag BMJ; Killestein J; de Vries HE
Mult Scler Relat Disord; 2019 Feb; 28():44-49. PubMed ID: 30553168
[TBL] [Abstract][Full Text] [Related]
2. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
[TBL] [Abstract][Full Text] [Related]
3. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
[TBL] [Abstract][Full Text] [Related]
4. Sphingomyelins and ceramides: possible biomarkers for dementia?
Loft LMI; Moseholm KF; Pedersen KKW; Jensen MK; Koch M; Cronjé HT
Curr Opin Lipidol; 2022 Feb; 33(1):57-67. PubMed ID: 34879042
[TBL] [Abstract][Full Text] [Related]
5. Alterations of plasma glycerophospholipid and sphingolipid species in male alcohol-dependent patients.
Reichel M; Hönig S; Liebisch G; Lüth A; Kleuser B; Gulbins E; Schmitz G; Kornhuber J
Biochim Biophys Acta; 2015 Nov; 1851(11):1501-10. PubMed ID: 26291032
[TBL] [Abstract][Full Text] [Related]
6. Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy.
Özer H; Aslan İ; Oruç MT; Çöpelci Y; Afşar E; Kaya S; Aslan M
Lipids Health Dis; 2018 Nov; 17(1):269. PubMed ID: 30474555
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies.
Axelsson M; Dubuisson N; Novakova L; Malmeström C; Giovannoni G; Lycke J; Gnanapavan S
Acta Neurol Scand; 2019 May; 139(5):422-427. PubMed ID: 30657162
[TBL] [Abstract][Full Text] [Related]
8. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia.
Arshad H; Alfonso JCL; Franke R; Michaelis K; Araujo L; Habib A; Zboromyrska Y; Lücke E; Strungaru E; Akmatov MK; Hatzikirou H; Meyer-Hermann M; Petersmann A; Nauck M; Brönstrup M; Bilitewski U; Abel L; Sievers J; Vila J; Illig T; Schreiber J; Pessler F
J Transl Med; 2019 Nov; 17(1):365. PubMed ID: 31711507
[TBL] [Abstract][Full Text] [Related]
9. Serum acid sphingomyelinase is upregulated in chronic hepatitis C infection and non alcoholic fatty liver disease.
Grammatikos G; Mühle C; Ferreiros N; Schroeter S; Bogdanou D; Schwalm S; Hintereder G; Kornhuber J; Zeuzem S; Sarrazin C; Pfeilschifter J
Biochim Biophys Acta; 2014 Jul; 1841(7):1012-20. PubMed ID: 24769340
[TBL] [Abstract][Full Text] [Related]
10. Systematic literature review and network meta-analysis in highly active relapsing-remitting multiple sclerosis and rapidly evolving severe multiple sclerosis.
Huisman E; Papadimitropoulou K; Jarrett J; Bending M; Firth Z; Allen F; Adlard N
BMJ Open; 2017 Mar; 7(3):e013430. PubMed ID: 28283486
[TBL] [Abstract][Full Text] [Related]
11. Elevation of Serum Acid Sphingomyelinase Activity in Acute Kawasaki Disease.
Konno Y; Takahashi I; Narita A; Takeda O; Koizumi H; Tamura M; Kikuchi W; Komatsu A; Tamura H; Tsuchida S; Noguchi A; Takahashi T
Tohoku J Exp Med; 2015 Oct; 237(2):133-40. PubMed ID: 26447086
[TBL] [Abstract][Full Text] [Related]
12. Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
van Doorn R; Nijland PG; Dekker N; Witte ME; Lopes-Pinheiro MA; van het Hof B; Kooij G; Reijerkerk A; Dijkstra C; van van der Valk P; van Horssen J; de Vries HE
Acta Neuropathol; 2012 Sep; 124(3):397-410. PubMed ID: 22810490
[TBL] [Abstract][Full Text] [Related]
13. Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod.
Ziemssen T; Kern R; Cornelissen C
BMC Neurol; 2016 Aug; 16():129. PubMed ID: 27502119
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a Neutral Sphingomyelinase Activity in Human Serum and Plasma.
Mühle C; Kornhuber J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768790
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
Holopainen JM; Subramanian M; Kinnunen PK
Biochemistry; 1998 Dec; 37(50):17562-70. PubMed ID: 9860872
[TBL] [Abstract][Full Text] [Related]
16. Sphingomyelin profiling in patients with diabetes could be potentially useful as differential diagnostics biomarker: A pilot study.
Sokołowska E; Car H; Fiedorowicz A; Szelachowska M; Milewska A; Wawrusiewicz-Kurylonek N; Szumowski P; Krzyżanowska-Grycel E; Popławska-Kita A; Żendzian-Piotrowska M; Chabowski A; Krętowski A; Siewko K
Adv Med Sci; 2022 Sep; 67(2):250-256. PubMed ID: 35785598
[TBL] [Abstract][Full Text] [Related]
17. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
18. Plasma Ceramide Species Are Associated with Diabetes Risk in Participants of the Strong Heart Study.
Fretts AM; Jensen PN; Hoofnagle A; McKnight B; Howard BV; Umans J; Yu C; Sitlani C; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
J Nutr; 2020 May; 150(5):1214-1222. PubMed ID: 31665380
[TBL] [Abstract][Full Text] [Related]
19. Is there a change of paradigm towards more effective treatment early in the course of apparent high-risk MS?
Fernández Ó
Mult Scler Relat Disord; 2017 Oct; 17():75-83. PubMed ID: 29055479
[TBL] [Abstract][Full Text] [Related]
20. Altered Levels of Serum Ceramide, Sphingosine and Sphingomyelin Are Associated with Colorectal Cancer: A Retrospective Pilot Study.
Separovic D; Shields AF; Philip PA; Bielawski J; Bielawska A; Pierce JS; Tarca AL
Anticancer Res; 2017 Mar; 37(3):1213-1218. PubMed ID: 28314284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
